Back

Active Clinical Trial Studies

Winnie Palmer Hospital for Women & Babies

To Make An Appointment

321.843.2584

Clinical Trials

Below is a list of currently active Phase II, III and IV trials. You can also search for a specific clinical trial using the field provided above.

  • Patent Ductus Arteriosus (PDA) Registry

    To track post-discharge outcomes for premature infants who are discharged from the NICU with a PDA. We plan to report on the spontaneous closure rate as well as incidence of adverse pulmonary and/or cardiac events in these infants.

  • GI Study for Intubated Preterm Babies

    To assess utility of biomarkers amylase and pepsin A compared with total pepsin from tracheal aspirates to diagnose microaspiration in patients requiring ventilation via endotracheal tube. The secondary objective is to look for a cytokine activity pattern that relates to the development of BPD.

  • Endotracheal Tube Position Study

    A pilot study to investigate the technical feasibility of recording breath sounds in intubated infants when the ETT position changes

  • Patent Ductus Arteriosus (PDA) Registry

    To track post-discharge outcomes for premature infants who are discharged from the NICU with a PDA. We plan to report on the spontaneous closure rate as well as incidence of adverse pulmonary and/or cardiac events in these infants.

  • GI Study for Intubated Preterm Babies

    To assess utility of biomarkers amylase and pepsin A compared with total pepsin from tracheal aspirates to diagnose microaspiration in patients requiring ventilation via endotracheal tube. The secondary objective is to look for a cytokine activity pattern that relates to the development of BPD.

  • Endotracheal Tube Position Study

    A pilot study to investigate the technical feasibility of recording breath sounds in intubated infants when the ETT position changes

  • Stem cell study for Hypoxic Ischemic Encephalopathy

    To evaluate the efficacy of up to two infusions of autologous umbilical cord blood in a prospective, randomized, double-blind, placebo controlled multi-center study.

  • Human milk-derived Cream Study

    To determine if infants who receive an exclusive HM-based diet with the addition of Prolact CR (Cream group) will have a shorter length of initial hospital stay compared to infants receiving the standard regimen of an exclusive HM-based diet (Control group) with no cream caloric supplement.